Related Experiment Videos
Monocyte esterase deficiency in malignant neoplasia
G M Markey1, J A McCormick, T C Morris
1Department of Haematology, Belfast City Hospital, Northern Ireland.
Journal of Clinical Pathology
|April 1, 1990
Summary
Monocyte esterase deficiency is more common in patients with malignant diseases and kidney issues. This finding suggests a potential role for reduced esterase activity in disease development.
Area of Science:
- Biochemistry
- Oncology
- Nephrology
Background:
- Monocyte esterase deficiency is a condition affecting immune cells.
- Its association with various diseases requires further investigation.
Purpose of the Study:
- To determine the incidence of monocyte esterase deficiency in patients with malignant neoplastic disease and renal disorders.
- To explore the familial occurrence of this deficiency.
Main Methods:
- Automated esterase assay performed on 4000 inpatients and 474 normal controls.
- Comparison of deficiency prevalence across different patient groups and familial relatives.
Main Results:
- A significant excess of monocyte esterase deficiency was observed in patients with malignant diseases compared to controls.
- Elevated deficiency rates were noted in chronic lymphocytic leukemia, lymphomas, gastrointestinal cancers, and renal unit patients.
- Familial incidence was found in 35% of first-degree relatives.
Conclusions:
- Monocyte esterase deficiency is significantly associated with specific malignant neoplastic diseases and renal disorders.
- The findings suggest a potential role for diminished esterase activity in the pathogenesis of these conditions.
- Familial clustering indicates a possible genetic component.